Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study
- 1 May 2013
- journal article
- research article
- Published by Elsevier BV in Clinical Microbiology & Infection
- Vol. 19 (5), E222-E229
- https://doi.org/10.1111/1469-0691.12134
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococciVaccine, 2011
- Anti-Group A Streptococcal Vaccine EpitopeJournal of Biological Chemistry, 2011
- Tissue Tropisms in Group a Streptococcal InfectionsFuture Microbiology, 2010
- emmand C-Repeat Region Molecular Typing of Beta-Hemolytic Streptococci in a Tropical Country: Implications for Vaccine DevelopmentJournal of Clinical Microbiology, 2009
- Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards ProtectionPLOS ONE, 2009
- Coiled-Coil Irregularities and Instabilities in Group A Streptococcus M1 Are Required for VirulenceScience, 2008
- Molecular typing ofStreptococcus pyogenesfrom remote Aboriginal communities where rheumatic fever is common and pyoderma is the predominant streptococcal infectionEpidemiology and Infection, 2007
- Differences between Belgian and Brazilian Group A Streptococcus Epidemiologic LandscapePLOS ONE, 2006
- emmTyping and Validation of Provisional M Types for Group A Streptococci1Emerging Infectious Diseases, 1999
- Structural heterogeneity of the emm gene cluster in group A streptococciMolecular Microbiology, 1993